sarpogrelate has been researched along with piperidines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heptinstall, S; Lösche, W; Sanderson, HM; Vickers, J | 1 |
| Asai, F; Fujimoto, K; Goto, R; Hayakawa, M; Ito, R; Ogawa, T; Sugidachi, A; Tanaka, N | 1 |
2 other study(ies) available for sarpogrelate and piperidines
| Article | Year |
|---|---|
Studies on the effects of agonists and antagonists on platelet shape change and platelet aggregation in whole blood.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adenosine Triphosphate; Azepines; Blood Platelets; Humans; In Vitro Techniques; Piperazines; Piperidines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Serotonin; Succinates; Sulfonamides; Thromboxane A2; Triazoles; Vasoconstrictor Agents | 1996 |
[2-(omega-phenylalkyl)phenoxy]alkylamines.II: Synthesis and selective serotonin-2 receptor binding.
Topics: Animals; Blood Platelets; Blood Vessels; Humans; In Vitro Techniques; Ketanserin; Phenyl Ethers; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrroles; Rats; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Receptors, Dopamine D2; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Structure-Activity Relationship; Succinates; Vasoconstriction | 2000 |